BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37973539)

  • 1. Keloidal atypical fibroxanthoma of the scalp.
    McClelland K; Brady A; Reid P; Houghton J
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37973539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent atypical fibroxanthoma with satellite metastasis.
    Lee SS; Lewis JM; Liaw K; Bushkell LL; Young YD; Googe PB
    J Cutan Pathol; 2015 Jan; 42(1):56-60. PubMed ID: 25407605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keloidal atypical fibroxanthoma: a case series.
    Kim J; McNiff JM
    J Cutan Pathol; 2009 May; 36(5):535-9. PubMed ID: 19476521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical fibroxanthoma-a diagnosis of exclusion!
    Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
    Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report.
    Smith-Zagone MJ; Prieto VG; Hayes RA; Timperman WW; Diwan AH
    J Cutan Pathol; 2004 Mar; 31(3):284-6. PubMed ID: 14984584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell atypical fibroxanthoma:a clinicopathologic study.
    Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
    J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical fibroxanthoma: new insights.
    Hussein MR
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
    Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
    Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A rare low-grade malignant scalp tumor. Atypical fibroxanthoma].
    Stepanova A; Marsch WC; Stadie V
    Hautarzt; 2005 Jul; 56(7):679-82. PubMed ID: 15726303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma mimicking atypical fibroxanthoma: Report of an unusual case.
    Wang Y; Guo Y
    J Cutan Pathol; 2021 Dec; 48(12):1493-1496. PubMed ID: 34258786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keloidal Atypical Fibroxanthoma: Case and Review of the Literature.
    Tongdee E; Touloei K; Shitabata PK; Shareef S; Maranda EL
    Case Rep Dermatol; 2016; 8(2):156-63. PubMed ID: 27462224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical fibroxanthoma of the scalp: overview and recent developments].
    Hilgers M; Wahl RU; Megahed M
    Hautarzt; 2014 Dec; 65(12):1008-10. PubMed ID: 25392128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
    Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
    Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomatoid Carcinoma With Quasi-Complete Loss of Cytokeratin Expression or Keratin-Positive Atypical Fibroxanthoma.
    Roy SF; Lafaille P; Désy D
    Int J Surg Pathol; 2019 Aug; 27(5):518-520. PubMed ID: 30760056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.